ISMRC 2023 Final Programme

Improve clinical outcomes with better MRD testing About Haystack MRD TM Haystack MRD is a tumor-informed circulating tumor DNA (ctDNA) test to detect and monitor residual and recurrent disease in solid tumor patients. The test is powered by Haystack Duo™ sequencing chemistry, which significantly reduces noise to detect even the least-abundant ctDNA molecules in blood. This unique ability translates to better minimal residual disease (MRD) detection for greater confidence when making key clinical decisions. www.haystackoncology.com Haystack Oncology, Inc. 301 West 29th Street, STE 2004U Baltimore, MD 21211 USA Haystack Oncology GmbH Luruper Hauptstr, 1 22547 Hamburg, Germany Stop by ISMRC Booth #1 to find out how Haystack Oncology delivers better MRD testing.